PLWH are often HCV coinfected and undergo more frequently to progressive disease. Early diagnosis and treatment are essential to eliminate HCV in this population. No-Co is a prospective cohort study on PLWH aimed to estimate: prevalence of past and active HCV infection in PLWH in care in 2017–2022, the incidence of HCV re-infections and HCV seroconversions and DAA- uptake and response.
Hepatitis Delta Virus (HDV) infection: frequency and outcome in Persons Living With HIV (PLWH). Data from the ICONA (Italian Cohort of Naïve for Antiretrovirals) cohort
Daniela SegalaMembro del Collaboration Group
2023
Abstract
PLWH are often HCV coinfected and undergo more frequently to progressive disease. Early diagnosis and treatment are essential to eliminate HCV in this population. No-Co is a prospective cohort study on PLWH aimed to estimate: prevalence of past and active HCV infection in PLWH in care in 2017–2022, the incidence of HCV re-infections and HCV seroconversions and DAA- uptake and response.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.